Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-171

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 43598-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This appears to be a description of an injectable drug called Thiotepa, with a dosage of 100mg/vial for intravenous, intracavitary, or intravesical use. The packaging includes a unique barcode and batch details, and instructions for storage and use after reconstitution. A cautionary note is included about the drug being a cytotoxic agent. The provided image appears to show the drug vial and its associated packaging, including dimensions and a 2D barcode.*

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Vial (Vial)

Thiotepa is a cytotoxic drug for intravenous, intracavitary, or intravesical use. It is sold as a prescription drug in single-dose vials by Dr. Reddy’s Laboratories Inc. The drug should be discarded if any unused portion remains. The usual dosage and other prescribing information are indicated in the pack. The drug is made in India and has a Drug Code No. AP/DRUGS/03/2011. Note that the text includes errors and truncated words.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.